Palisade Bio (PALI) Revenue (2011 - 2026)
Palisade Bio (PALI) posted quarterly Revenue of $250000.0 for Q1 2023, up 9900.0% quarter-over-quarter from $2500.0 in Q4 2020.
Palisade Bio (PALI) Revenue (2011 - 2026) Analysis & Trends
Palisade Bio (PALI) has reported Revenue for 11 consecutive years, with $250000.0 the latest figure, recorded in Q1 2023.
- In Q1 2023, Revenue changed N/A year-over-year to $250000.0; the TTM figure through Dec 2023 stood at $250000.0 (changed N/A YoY), while the FY2023 annual figure was $250000.0, changed N/A from the prior year.
- Revenue rose to $250000.0 in Q1 2023 per PALI's latest filing, from $2500.0 in the prior quarter.
- Across five years, Revenue topped out at $250000.0 in Q1 2023 and bottomed at $2500.0 in Q1 2019.
- Historically, Revenue has averaged $30990.4 across 3 years, with a median of $2500.0 in 2019.
- Annual changes were most pronounced in 2019 — Revenue tumbled 96.87% — and 2020, when it jumped 140.8%.
- Palisade Bio's Revenue stood at $2500.0 in 2019, then changed by 0.0% to $2500.0 in 2020, then soared by 9900.0% to $250000.0 in 2023.
- Business Quant data shows PALI's Revenue at $250000.0 in Q1 2023, $2500.0 in Q4 2020, and $2500.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Palisade Bio | 372.94 Mn | 247.74 Mn | - | 500,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 500,000.00 |
| Mar 31, 2023 | 250,000.00 |
| Dec 31, 2020 | 2,500.00 |
| Sep 30, 2020 | 2,500.00 |
| Jun 30, 2020 | 2,500.00 |
| Mar 31, 2020 | 6,020.00 |
| Dec 31, 2019 | 2,500.00 |
| Sep 30, 2019 | 2,500.00 |
| Jun 30, 2019 | 7,894.00 |
| Mar 31, 2019 | 2,500.00 |
| Dec 31, 2018 | 2,500.00 |
| Sep 30, 2018 | 2,500.00 |
| Jun 30, 2018 | 252,500.00 |
| Mar 31, 2018 | 2,500.00 |
| Dec 31, 2017 | 252,500.00 |
| Sep 30, 2017 | 2,500.00 |
| Jun 30, 2017 | 2,500.00 |
| Mar 31, 2017 | 2,500.00 |
| Dec 31, 2016 | 8,746.00 |
| Sep 30, 2016 | 2,500.00 |